Moexipril
194 interactions 444 cited referencesMoexipril is an ACE inhibitor medication used to treat high blood pressure. Read the full Moexipril drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Moderate
Moexipril Floctafenine Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Flufenamic Acid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Glyburide DiaBeta® An increased risk of hypoglycemia Details Moexipril Gold Sodium Thiomalate Nitritoid reactions (facial flushing, nausea, vomiting, and hypotension) Details Moexipril Hydrochlorothiazide Inzirqo Reduction of blood pressure Details Moexipril Hydroflumethiazide Reduction of blood pressure Details Moexipril Icatibant Firazyr Reduced moexipril effectiveness Details Moexipril Indapamide Reduction of blood pressure Details Moexipril Indomethacin Indocin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Insulin Afrezza An increased risk of hypoglycemia Details Moexipril Insulin Aspart, Recombinant Fiasp An increased risk of hypoglycemia Details Moexipril Insulin Bovine An increased risk of hypoglycemia Details Moexipril Insulin Degludec Tresiba An increased risk of hypoglycemia Details Moexipril Insulin Detemir Levemir An increased risk of hypoglycemia Details Moexipril Insulin Glargine, Recombinant Basaglar An increased risk of hypoglycemia Details Moexipril Insulin Glulisine Apidra An increased risk of hypoglycemia Details Moexipril Insulin Lispro, Recombinant Admelog An increased risk of hypoglycemia Details Moexipril Lanthanum Carbonate Fosrenol Reduced bioavailability of ACE inhibitors Details Moexipril Liraglutide Saxenda An increased risk of hypoglycemia Details Moexipril Lixisenatide An increased risk of hypoglycemia Details Moexipril Lornoxicam Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Loxoprofen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Lumiracoxib Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Ma Huang Reduced effectiveness of angiotensin converting enzyme inhibitors Details Moexipril Methyclothiazide Reduction of blood pressure Details Moexipril Metolazone Reduction of blood pressure Details Moexipril Morniflumate Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Nabumetone Relafen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Naproxen Aleve Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Nateglinide Starlix® An increased risk of hypoglycemia Details Moexipril Nepafenac Ilevro Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Nesiritide Increase in symptomatic hypotension Details Moexipril Niflumic Acid Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Nimesulide Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Nimesulide Beta Cyclodextrin Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Oxaprozin Coxanto Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Oxyphenbutazone Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Parecoxib Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Phenylbutazone Equi-Phar Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure Details Moexipril Piketoprofen Reduced antihypertensive effect and renal dysfunction and/or increased blood pressure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist